Lamprene Interactions
There are 301 drugs known to interact with Lamprene (clofazimine), along with 3 disease interactions. Of the total drug interactions, 116 are major, 184 are moderate, and 1 is minor.
- View all 301 medications that may interact with Lamprene
- View Lamprene disease interactions (3)
Most frequently checked interactions
View interaction reports for Lamprene (clofazimine) and the medicines listed below.
- Advate (antihemophilic factor)
- Afinitor Disperz (everolimus)
- amlodipine
- Asmanex Twisthaler (mometasone)
- Ativan (lorazepam)
- Avastin (bevacizumab)
- azithromycin
- Bactrim (sulfamethoxazole / trimethoprim)
- Celebrex (celecoxib)
- CellCept (mycophenolate mofetil)
- Ceprotin (protein c)
- Coumadin (warfarin)
- Cymbalta (duloxetine)
- dapsone
- Depakene (valproic acid)
- doxycycline
- Epidiolex (cannabidiol)
- estradiol / norethindrone
- ethambutol
- Fabrazyme (agalsidase beta)
- heparin
- Humira (adalimumab)
- Isuprel (isoproterenol)
- Kalydeco (ivacaftor)
- leucovorin
- Lyrica (pregabalin)
- methadone
- omeprazole
- prednisone
- Vitamin D3 (cholecalciferol)
Lamprene disease interactions
There are 3 disease interactions with Lamprene (clofazimine) which include:
More about Lamprene (clofazimine)
- Lamprene consumer information
- Compare alternatives
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: leprostatics
- Breastfeeding
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.